BiomX Provides a Program Update and Announces New FDA Feedback Potentially Expanding BX004 Development Pathways
BiomX believes that it has fully addressed the FDA’s queries related to the third-party nebulizer used to deliver BX004, which...
Day: October 17, 2025
QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025
FDA-approved MTS™ DAT Card and advanced ORTHO VISION™ Platform highlight the company's continued leadership in transfusion medicine SAN DIEGO, Oct. 16,...